CONCORD ACQUISITION CORP -A (CNDA) Stock Fundamental Analysis

NYSEARCA:CNDA • US20607U1088

10.5 USD
0 (0%)
Last: Aug 30, 2024, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CNDA. CNDA was compared to 0 industry peers in the Unkown industry. CNDA has a bad profitability rating. Also its financial health evaluation is rather negative. CNDA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CNDA was profitable.
  • In the past year CNDA has reported a negative cash flow from operations.
CNDA Yearly Net Income VS EBIT VS OCF VS FCFCNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 13.12%
ROE 23.37%
ROIC N/A
ROA(3y)3.62%
ROA(5y)N/A
ROE(3y)3.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNDA Yearly ROA, ROE, ROICCNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 4

1.3 Margins

  • CNDA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNDA Yearly Profit, Operating, Gross MarginsCNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for CNDA has been reduced compared to 1 year ago.
  • CNDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNDA Yearly Shares OutstandingCNDA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
CNDA Yearly Total Debt VS Total AssetsCNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

  • CNDA has an Altman-Z score of 11.82. This indicates that CNDA is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.04 indicates that CNDA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 11.82
ROIC/WACCN/A
WACCN/A
CNDA Yearly LT Debt VS Equity VS FCFCNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • CNDA has a Current Ratio of 0.15. This is a bad value and indicates that CNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CNDA has a Quick Ratio of 0.15. This is a bad value and indicates that CNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
CNDA Yearly Current Assets VS Current LiabilitesCNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for CNDA have decreased strongly by -45.85% in the last year.
EPS 1Y (TTM)-45.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 70.00, the valuation of CNDA can be described as expensive.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, CNDA is valued quite expensively.
Industry RankSector Rank
PE 70
Fwd PE N/A
CNDA Price Earnings VS Forward Price EarningsCNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNDA Per share dataCNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CNDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CONCORD ACQUISITION CORP -A

NYSEARCA:CNDA (8/30/2024, 8:04:01 PM)

10.5

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-02
Earnings (Next)N/A
Inst Owners8.07%
Inst Owner Change-19.3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Revenue(TTM)N/A
Net Income(TTM)3.16M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 70
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 16.84
P/tB 16.84
EV/EBITDA N/A
EPS(TTM)0.15
EY1.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS0.62
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.12%
ROE 23.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.62%
ROA(5y)N/A
ROE(3y)3.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z 11.82
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-74.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.85%
OCF growth 3YN/A
OCF growth 5YN/A

CONCORD ACQUISITION CORP -A / CNDA FAQ

What is the fundamental rating for CNDA stock?

ChartMill assigns a fundamental rating of 1 / 10 to CNDA.


Can you provide the valuation status for CONCORD ACQUISITION CORP -A?

ChartMill assigns a valuation rating of 0 / 10 to CONCORD ACQUISITION CORP -A (CNDA). This can be considered as Overvalued.


What is the profitability of CNDA stock?

CONCORD ACQUISITION CORP -A (CNDA) has a profitability rating of 0 / 10.


What are the PE and PB ratios of CONCORD ACQUISITION CORP -A (CNDA) stock?

The Price/Earnings (PE) ratio for CONCORD ACQUISITION CORP -A (CNDA) is 70 and the Price/Book (PB) ratio is 16.84.